In models of subarachnoid hemorrhage and multiple sclerosis, gene suppression or pharmacological inhibition (glibenclamide) of Abcc8/Sur1 significantly ameliorates neuroinflammation and improves neurological function, with these effects attributed to inhibition of Sur1-Trpm4 channels [36–38]. Here, ABCC8 is linked to subarachnoid hemorrhage.